BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 2, 2000
View Archived Issues
Northwest's prostate cancer vaccine shows favorable progress in clinical trial
Read More
Endo meets with FDA to clarify requirements for MorphiDex approval
Read More
FDA completes review of supplemental BLA for Rituxan
Read More
Salus receives NIH grant to aid in development of anti-HIV treatment
Read More
Angiogenic activity suggests broadened role for statins
Read More
Hollis-Eden cleared to commence further HIV clinical trials in South Africa
Read More
Interferon beta delays development of multiple sclerosis in high-risk subjects
Read More
SBIR grant awarded to Imgenex to develop monoclonal antibodies for osteoporosis
Read More
Newly synthesized selective AMPA agonist used to elucidate receptor function
Read More
Acidic quinolones with potent antibacterial activity identified at Wakunaga
Read More
Servier investigates synergistic interaction between alpha2 blockade and monoamine uptake inhibition
Read More
Sigma-Tau selects new camptothecin derivative for preclinical development
Read More
Potent adenosine transporter inhibitors synthesized by Kyowa Hakko useful as tools and leads
Read More
FDA approves Mifeprex for termination of early pregnancy
Read More
New approach to oncolytic, skin disorders based on specific inhibition of 4-hydroxylase
Read More
First oral drug for rare neurodegenerative disease launched in Japan
Read More
Selective COX-2 inhibitor with promising profile emerges from Abbott R&D
Read More
Efficacy in experimental IBD demonstrated for immunosteroid recently acquired by Hollis-Eden
Read More
Two new patents cover VCAM-1/VLA-4 inhibitors from Roche and their use
Read More
Beacon describes preparation and activity of improved butyric acid esters
Read More
Meiosis-regulating cholestane compounds designed by Schering
Read More
Newly isolated antibiotic characterized at Pola as having antifungal and antibacterial activity
Read More
Chugai examines novel enzyme inhibitors as potential anticancer agents
Read More
Migration-inhibitory peptides identified and investigated at Kyowa Hakko
Read More
New vitamin D compounds for bone disorders prepared at Sumitomo
Read More
Taiho describes new series for use in reducing elevated ammonia levels
Read More
Bosentan begins FDA approval process for pulmonary hypertension
Read More
Ligand's lasofoxifene enters phase III for osteoporosis, triggering milestone payment
Read More